M
Melissa Frei-Jones
Researcher at University of Texas Health Science Center at San Antonio
Publications - 20
Citations - 1418
Melissa Frei-Jones is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Medicine & Newborn screening. The author has an hindex of 9, co-authored 17 publications receiving 1173 citations. Previous affiliations of Melissa Frei-Jones include University of Texas Southwestern Medical Center & Texas A&M University.
Papers
More filters
Journal ArticleDOI
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Kathryn G. Roberts,Yongjin Li,Debbie Payne-Turner,Richard C. Harvey,Yung-Li Yang,Dehua Pei,Kelly McCastlain,Li Ding,Li Ding,Changxue Lu,Changxue Lu,Guangchun Song,Jing Ma,Jared Becksfort,Michael Rusch,S. C. Chen,John Easton,J. Cheng,Kristy Boggs,Natalia Santiago-Morales,Ilaria Iacobucci,Robert S. Fulton,Robert S. Fulton,Ji Wen,Marcus B. Valentine,Cheng Cheng,Steven W. Paugh,Meenakshi Devidas,Meenakshi Devidas,I-Ming Chen,S. Reshmi,S. Reshmi,Amy Smith,Erin Hedlund,Pankaj Gupta,Panduka Nagahawatte,Gang Wu,Xiang Chen,Donald Yergeau,Bhavin Vadodaria,Heather L. Mulder,Naomi J. Winick,Eric Larsen,William L. Carroll,William L. Carroll,Nyla A. Heerema,Andrew J. Carroll,G. Grayson,Sarah K. Tasian,Andrew S. Moore,F. Keller,Melissa Frei-Jones,J. A. Whitlock,Elizabeth A. Raetz,Deborah L. White,Timothy P. Hughes,J. M. Guidry Auvil,Malcolm A. Smith,Malcolm A. Smith,Guido Marcucci,Clara D. Bloomfield,Krzysztof Mrózek,Jessica Kohlschmidt,Jessica Kohlschmidt,Wendy Stock,Steven M. Kornblau,Marina Konopleva,Elisabeth Paietta,Ching-Hon Pui,Sima Jeha,Mary V. Relling,William E. Evans,Daniela S. Gerhard,Julie M. Gastier-Foster,Julie M. Gastier-Foster,Elaine R. Mardis,Richard K. Wilson,Mignon L. Loh,Mignon L. Loh,James R. Downing,James R. Downing,Stephen P. Hunger,Stephen P. Hunger,Cheryl L. Willman,Cheryl L. Willman,Jinghui Zhang,Charles G. Mullighan,Charles G. Mullighan +87 more
TL;DR: Ph-like ALL was found to be characterized by a range of genomic alterations that activate a limited number of signaling pathways, all of which may be amenable to inhibition with approved tyrosine kinase inhibitors.
Journal ArticleDOI
Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease.
Bernadette R. Gochuico,Marjan Huizing,Gretchen Golas,Charles D. Scher,Maria Tsokos,Stacey D Denver,Melissa Frei-Jones,William A. Gahl +7 more
TL;DR: Data show that children and young adults with HPS-2 and functional defects of the AP-3 complex are at risk for ILD and pulmonary fibrosis.
Journal ArticleDOI
The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2
Birthe Jessen,Sebastian F. N. Bode,Sandra Ammann,Subarna Chakravorty,Graham Davies,Jana Diestelhorst,Melissa Frei-Jones,William A. Gahl,Bernadette R. Gochuico,Matthias Griese,Gillian M. Griffiths,Gritta Janka,Christoph Klein,Tamara Kögl,Karin Kurnik,Kai Lehmberg,Andrea Maul-Pavicic,Andrew D Mumford,David Pace,Nima Parvaneh,Nima Rezaei,Geneviève de Saint Basile,Annette Schmitt-Graeff,Klaus Schwarz,Gulsun Karasu,Barbara Zieger,Udo zur Stadt,Peter Aichele,Stephan Ehl +28 more
TL;DR: HPS2 confers a risk for HLH that is lower than in Griscelli or Chediak-Higashi syndrome, probably because of a milder defect in cytotoxicity, and preemptive hematopoietic stem cell transplantation does not appear justified in HPS2.
Journal ArticleDOI
Thromboelastography—does it impact blood component transfusion in pediatric heart surgery?
TL;DR: Intraoperative TEG use reduced platelet and cryoprecipitate transfusions without an increase in postoperative complications shows that TEG is a cost-effective method to direct blood product replacement.
Journal ArticleDOI
Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome.
TL;DR: Pain in children with sickle cell disease is the leading cause of acute care visits and hospitalizations, and pain episodes are a risk factor for the development of acute chest syndrome.